Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

844 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.
Ye Z, Wang C, Wan S, Mu Z, Zhang Z, Abu-Khalaf MM, Fellin FM, Silver DP, Neupane M, Jaslow RJ, Bhattacharya S, Tsangaris TN, Chervoneva I, Berger A, Austin L, Palazzo JP, Myers RE, Pancholy N, Toorkey D, Yao K, Krall M, Li X, Chen X, Fu X, Xing J, Hou L, Wei Q, Li B, Cristofanilli M, Yang H. Ye Z, et al. Among authors: mu z. Eur J Cancer. 2019 Jan;106:133-143. doi: 10.1016/j.ejca.2018.10.012. Epub 2018 Dec 4. Eur J Cancer. 2019. PMID: 30528798 Free PMC article.
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.
Wang C, Mu Z, Ye Z, Zhang Z, Abu-Khalaf MM, Silver DP, Palazzo JP, Jagannathan G, Fellin FM, Bhattacharya S, Jaslow RJ, Tsangaris TN, Berger A, Neupane M, Cescon TP, Lopez A, Yao K, Chong W, Lu B, Myers RE, Hou L, Wei Q, Li B, Cristofanilli M, Yang H. Wang C, et al. Among authors: mu z. Breast Cancer Res Treat. 2020 Jun;181(3):679-689. doi: 10.1007/s10549-020-05662-x. Epub 2020 May 4. Breast Cancer Res Treat. 2020. PMID: 32367460 Free PMC article.
Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer.
Gerratana L, Davis AA, Zhang Q, Basile D, Rossi G, Strickland K, Franzoni A, Allegri L, Mu Z, Zhang Y, Flaum LE, Damante G, Gradishar WJ, Platanias LC, Behdad A, Yang H, Puglisi F, Cristofanilli M. Gerratana L, et al. Among authors: mu z. JCO Precis Oncol. 2021 Jun 8;5:943-952. doi: 10.1200/PO.20.00345. eCollection 2021 Jun. JCO Precis Oncol. 2021. PMID: 34136741 Free PMC article.
The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based study.
Lai Y, Ye Z, Civan JM, Wang C, Cristofanilli M, Mu Z, Austin L, Palazzo JP, Myers RE, Yang H. Lai Y, et al. Among authors: mu z. Breast Cancer Res Treat. 2015 Sep;153(2):407-16. doi: 10.1007/s10549-015-3532-y. Epub 2015 Aug 12. Breast Cancer Res Treat. 2015. PMID: 26264468
844 results